On Ver­tex and CRISPR Ther­a­peu­tics’ heels, blue­bird sub­mits sick­le cell gene ther­a­py to FDA

Blue­bird bio said Mon­day morn­ing it has sub­mit­ted an ap­pli­ca­tion for its sick­le cell ther­a­py to the FDA for po­ten­tial ap­proval …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.